Cargando…

Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice

Human immunodeficiency virus type 1 (HIV-1) infection is associated with aberrant immune activation; however, most model systems for HIV-1 have been used during established infection. Here, we utilize ultrasensitive HIV-1 quantification to delineate early events during the eclipse, burst, and chroni...

Descripción completa

Detalles Bibliográficos
Autores principales: Skelton, Jessica Katy, Ortega-Prieto, Ana Maria, Kaye, Steve, Jimenez-Guardeño, Jose Manuel, Turner, Jane, Malim, Michael H., Towers, Greg J., Dorner, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532090/
https://www.ncbi.nlm.nih.gov/pubmed/30867315
http://dx.doi.org/10.1128/JVI.02123-18
_version_ 1783420937650044928
author Skelton, Jessica Katy
Ortega-Prieto, Ana Maria
Kaye, Steve
Jimenez-Guardeño, Jose Manuel
Turner, Jane
Malim, Michael H.
Towers, Greg J.
Dorner, Marcus
author_facet Skelton, Jessica Katy
Ortega-Prieto, Ana Maria
Kaye, Steve
Jimenez-Guardeño, Jose Manuel
Turner, Jane
Malim, Michael H.
Towers, Greg J.
Dorner, Marcus
author_sort Skelton, Jessica Katy
collection PubMed
description Human immunodeficiency virus type 1 (HIV-1) infection is associated with aberrant immune activation; however, most model systems for HIV-1 have been used during established infection. Here, we utilize ultrasensitive HIV-1 quantification to delineate early events during the eclipse, burst, and chronic phases of HIV-1 infection in humanized mice. We show that very early in infection, HIV-1 suppresses peripheral type I interferon (IFN) and interferon-stimulated gene (ISG) responses, including the HIV-1 restriction factor IFI44. At the peak of innate immune activation, prior to CD4 T cell loss, HIV-1 infection differentially affects peripheral and lymphoid Toll-like receptor (TLR) expression profiles in T cells and macrophages. This results in a trend toward an altered activation of nuclear factor κB (NF-κB), TANK-binding kinase 1 (TBK1), and interferon regulatory factor 3 (IRF3). The subsequent type I and III IFN responses result in preferential induction of peripheral ISG responses. Following this initial innate immune activation, peripheral expression of the HIV-1 restriction factor SAM domain- and HD domain-containing protein 1 (SAMHD1) returns to levels below those observed in uninfected mice, suggesting that HIV-1 interferes with their basal expression. However, peripheral cells still retain their responsiveness to exogenous type I IFN, whereas splenic cells show a reduction in select ISGs in response to IFN. This demonstrates the highly dynamic nature of very early HIV-1 infection and suggests that blocks to the induction of HIV-1 restriction factors contribute to the establishment of viral persistence. IMPORTANCE Human immunodeficiency virus type 1 (HIV-1) infection is restricted to humans and some nonhuman primates (e.g., chimpanzee and gorilla). Alternative model systems based on simian immunodeficiency virus (SIV) infection of macaques are available but do not recapitulate all aspects of HIV-1 infection and disease. Humanized mice, which contain a human immune system, can be used to study HIV-1, but only limited information on early events and immune responses is available to date. Here, we describe very early immune responses to HIV-1 and demonstrate a suppression of cell-intrinsic innate immunity. Furthermore, we show that HIV-1 infection interacts differently with innate immune responses in blood and lymphoid organs.
format Online
Article
Text
id pubmed-6532090
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-65320902019-06-03 Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice Skelton, Jessica Katy Ortega-Prieto, Ana Maria Kaye, Steve Jimenez-Guardeño, Jose Manuel Turner, Jane Malim, Michael H. Towers, Greg J. Dorner, Marcus J Virol Cellular Response to Infection Human immunodeficiency virus type 1 (HIV-1) infection is associated with aberrant immune activation; however, most model systems for HIV-1 have been used during established infection. Here, we utilize ultrasensitive HIV-1 quantification to delineate early events during the eclipse, burst, and chronic phases of HIV-1 infection in humanized mice. We show that very early in infection, HIV-1 suppresses peripheral type I interferon (IFN) and interferon-stimulated gene (ISG) responses, including the HIV-1 restriction factor IFI44. At the peak of innate immune activation, prior to CD4 T cell loss, HIV-1 infection differentially affects peripheral and lymphoid Toll-like receptor (TLR) expression profiles in T cells and macrophages. This results in a trend toward an altered activation of nuclear factor κB (NF-κB), TANK-binding kinase 1 (TBK1), and interferon regulatory factor 3 (IRF3). The subsequent type I and III IFN responses result in preferential induction of peripheral ISG responses. Following this initial innate immune activation, peripheral expression of the HIV-1 restriction factor SAM domain- and HD domain-containing protein 1 (SAMHD1) returns to levels below those observed in uninfected mice, suggesting that HIV-1 interferes with their basal expression. However, peripheral cells still retain their responsiveness to exogenous type I IFN, whereas splenic cells show a reduction in select ISGs in response to IFN. This demonstrates the highly dynamic nature of very early HIV-1 infection and suggests that blocks to the induction of HIV-1 restriction factors contribute to the establishment of viral persistence. IMPORTANCE Human immunodeficiency virus type 1 (HIV-1) infection is restricted to humans and some nonhuman primates (e.g., chimpanzee and gorilla). Alternative model systems based on simian immunodeficiency virus (SIV) infection of macaques are available but do not recapitulate all aspects of HIV-1 infection and disease. Humanized mice, which contain a human immune system, can be used to study HIV-1, but only limited information on early events and immune responses is available to date. Here, we describe very early immune responses to HIV-1 and demonstrate a suppression of cell-intrinsic innate immunity. Furthermore, we show that HIV-1 infection interacts differently with innate immune responses in blood and lymphoid organs. American Society for Microbiology 2019-05-15 /pmc/articles/PMC6532090/ /pubmed/30867315 http://dx.doi.org/10.1128/JVI.02123-18 Text en Copyright © 2019 Skelton et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Cellular Response to Infection
Skelton, Jessica Katy
Ortega-Prieto, Ana Maria
Kaye, Steve
Jimenez-Guardeño, Jose Manuel
Turner, Jane
Malim, Michael H.
Towers, Greg J.
Dorner, Marcus
Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
title Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
title_full Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
title_fullStr Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
title_full_unstemmed Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
title_short Kinetics of Early Innate Immune Activation during HIV-1 Infection of Humanized Mice
title_sort kinetics of early innate immune activation during hiv-1 infection of humanized mice
topic Cellular Response to Infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532090/
https://www.ncbi.nlm.nih.gov/pubmed/30867315
http://dx.doi.org/10.1128/JVI.02123-18
work_keys_str_mv AT skeltonjessicakaty kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice
AT ortegaprietoanamaria kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice
AT kayesteve kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice
AT jimenezguardenojosemanuel kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice
AT turnerjane kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice
AT malimmichaelh kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice
AT towersgregj kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice
AT dornermarcus kineticsofearlyinnateimmuneactivationduringhiv1infectionofhumanizedmice